PKM2 inhibition may reverse therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma

BACKGROUND: Therapeutic options for patients with hepatocellular carcinoma (HCC) are limited. Transarterial chemoembolization (TACE) is an interventional procedure used to deliver chemotherapy and embolizing agents directly to the tumor and is the procedure of choice for patients with intermediate s...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin, Sean P., Fako, Valerie, Dang, Hien, Dominguez, Dana A., Khatib, Subreen, Ma, Lichun, Wang, Haiyang, Zheng, Wei, Wang, Xin Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268641/
https://www.ncbi.nlm.nih.gov/pubmed/32487192
http://dx.doi.org/10.1186/s13046-020-01605-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268641/
https://www.ncbi.nlm.nih.gov/pubmed/32487192
http://dx.doi.org/10.1186/s13046-020-01605-y

Ejemplares similares